283 related articles for article (PubMed ID: 24018165)
1. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease.
Tian Y; Wong VW; Chan HL; Cheng AS
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):471-82. PubMed ID: 24018165
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
Baffy G; Brunt EM; Caldwell SH
J Hepatol; 2012 Jun; 56(6):1384-91. PubMed ID: 22326465
[TBL] [Abstract][Full Text] [Related]
3. Obesity, insulin resistance, NASH and hepatocellular carcinoma.
Yu J; Shen J; Sun TT; Zhang X; Wong N
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):483-91. PubMed ID: 23876851
[TBL] [Abstract][Full Text] [Related]
4. Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.
Tokushige K; Hashimoto E; Kodama K
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():88-92. PubMed ID: 24251711
[TBL] [Abstract][Full Text] [Related]
5. Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.
Tian Y; Wong VW; Wong GL; Yang W; Sun H; Shen J; Tong JH; Go MY; Cheung YS; Lai PB; Zhou M; Xu G; Huang TH; Yu J; To KF; Cheng AS; Chan HL
Cancer Res; 2015 Nov; 75(22):4803-16. PubMed ID: 26383163
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
Torres DM; Harrison SA
Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
8. Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).
Podrini C; Borghesan M; Greco A; Pazienza V; Mazzoccoli G; Vinciguerra M
Curr Pharm Des; 2013; 19(15):2737-46. PubMed ID: 23092327
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
Herceg Z; Paliwal A
Mutat Res; 2011; 727(3):55-61. PubMed ID: 21514401
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
11. NAFLD leads to liver cancer: do we have sufficient evidence?
Duan XY; Zhang L; Fan JG; Qiao L
Cancer Lett; 2014 Apr; 345(2):230-4. PubMed ID: 23941829
[TBL] [Abstract][Full Text] [Related]
12. NASH and HCC.
Page JM; Harrison SA
Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology, risk factors and molecular pathogenesis of primary liver cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2008 Mar; 149(12):541-8. PubMed ID: 18343770
[TBL] [Abstract][Full Text] [Related]
14. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients.
Jain D; Nayak NC; Saigal S
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):840-8. PubMed ID: 22495397
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis.
Tian Y; Mok MT; Yang P; Cheng AS
Cancers (Basel); 2016 Aug; 8(8):. PubMed ID: 27556491
[TBL] [Abstract][Full Text] [Related]
17. Genomic aspects of NAFLD pathogenesis.
Naik A; Košir R; Rozman D
Genomics; 2013 Aug; 102(2):84-95. PubMed ID: 23545492
[TBL] [Abstract][Full Text] [Related]
18. Obesity-associated mechanisms of hepatocarcinogenesis.
Karagozian R; Derdák Z; Baffy G
Metabolism; 2014 May; 63(5):607-17. PubMed ID: 24629562
[TBL] [Abstract][Full Text] [Related]
19. Potential epigenetic mechanism in non-alcoholic Fatty liver disease.
Sun C; Fan JG; Qiao L
Int J Mol Sci; 2015 Mar; 16(3):5161-79. PubMed ID: 25751727
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.
Kutlu O; Kaleli HN; Ozer E
Can J Gastroenterol Hepatol; 2018; 2018():8543763. PubMed ID: 30228976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
